Icecure Medical is trading at $0.96, down 12.72%, with broader-market pressure the likeliest context for the October 14 decline, not a confirmed company-specific cause. - September inflation came in hotter than expected, strengthening expectations of higher-for-longer rates and weighing on stocks. - The latest company release, on October 13, discussed clinical data and physician engagement at EUSOBI.